Drugs & Aging

, Volume 2, Issue 1, pp 35–41 | Cite as

Drug-Induced Hypokalaemia

A Cause for Concern
  • Gerald Isaac
  • O. Bryan Holland
Review Article Adverse Effects

Summary

Drug-induced hypokalaemia is a widespread problem in the elderly that can be caused by many therapeutically useful substances, the most common of which are diuretics. In certain classes of patients (e.g. those with acute myocardial infarction, with congestive heart failure receiving digitalis, or with cirrhosis), iatrogenic hypokalaemia is an established risk factor. In patients with hypertension who have no underlying heart disease or liver disease, the use of diuretics may lead to worsened glucose tolerance and cardiac arrythmias. There is also evidence for an increased risk of sudden cardiac death.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barden TP, Peter JB, Merkatz IR. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. I. Pharmacology, clinical history, adminsitration, side effects, and safety. Obstetrics and Gynecology 56: 1–6, 1980PubMedGoogle Scholar
  2. Bengtsson C, Blohme G, Lapidus L. Do antihypertensive drugs precipitate diabetes? British Medical Journal 289: 1495–1497, 1984PubMedCrossRefGoogle Scholar
  3. Berglund G, Andersson O, Widgren B. Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10 year controlled trial with bendroflumethiazide. Acta Medica Scandinavica 220: 419–424, 1986PubMedCrossRefGoogle Scholar
  4. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. New England Journal of Medicine 309: 1414–1419, 1983PubMedCrossRefGoogle Scholar
  5. Cort JH, Matthews HL. Potassium deficiency in congestive heart failure: three cases with hyponatremia, including results of potassium replacement in one case. Lancet 1: 1202–1206, 1954CrossRefGoogle Scholar
  6. Dyckner T, Wester PO, Widman L. Amiloride prevents thiazide-induced intracellular potassium and magnesium losses. Acta Medica Scandinavica 224: 25–30, 1988PubMedCrossRefGoogle Scholar
  7. Fukuchi S, Hanata M, Takahashi H. The relationship between vascular reactivity and extracellular potassium. Tohoku Journal of Experimental Medicine 85: 181–191, 1965PubMedCrossRefGoogle Scholar
  8. Gifford RW. A guide to the practical use of diuretics. Journal of the American Medical Association 235: 1890–1983, 1976PubMedCrossRefGoogle Scholar
  9. Halevy J, Gunsherowitz M, Rosenfield JB. Life-threatening hypokalemia in hospitalized patients. Mineral and Electrolyte Metabolism 14: 163–166, 1988PubMedGoogle Scholar
  10. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32: 106–111, 1983PubMedCrossRefGoogle Scholar
  11. Hermansen K, Schmitz O, Mogensen CE. Effects of a thiazide diuretic (hydroflumethiazide) and a loop diuretic (bumetanide) on the endocrine pancreas: studies in vitro. Metabolism 34: 784–789, 1985PubMedCrossRefGoogle Scholar
  12. Holland OB. Mild hypokalemia in non-edematous, non-digitalized patients: the case for routinely normalizing serum potassium. In Narins RG (Ed.) Controversies in nephrology and hypertension, pp. 345–358, Churchill Livingstone, New York, 1984Google Scholar
  13. Holland OB. Potassium loss, ventricular irritability, and the risk of sudden death in hypertensive patients. Drugs 31 (Suppl. 4): 78–84, 1986PubMedCrossRefGoogle Scholar
  14. Holland OB, Gomez-Sanchez C, Kuhnert L, Poindexter C, Pak CYC. Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients. Archives of Internal Medicine 139: 1365–1370, 1979PubMedCrossRefGoogle Scholar
  15. Holland OB, Kuhnert LV, Campbell WB, Anderson RJ. Synergistic effect of captopril with hydrocholorothiazide for the treatment of low-renin hypertensive black patients. Hypertension 5: 235–239, 1983PubMedCrossRefGoogle Scholar
  16. Holland OB, Kuhnert LV, Pollard J, Padia M, Anderson RJ, et al. Ventricular ectopic activity with diuretic therapy. American Journal of Hypertension 1: 380–385, 1988PubMedGoogle Scholar
  17. Holland OB, Nixon JV, Kuhnert L. Diuretic-induced ventricular ectopic activity. American Journal of Medicine 70: 762–768, 1981PubMedCrossRefGoogle Scholar
  18. Hollifield JW, Slaton PE. Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Medica Scandinavica 647 (Suppl.): 67–73, 1981PubMedGoogle Scholar
  19. Iacobellis M, Muntwyler E, Griffin GE. Kidney glutaminase and carbonic anhydrase activity and tissue electrolyte composition in potassium-deficient dogs. American Journal of Physiology 1983: 395–400, 1995Google Scholar
  20. Jacobs DB, Mookerjee BK, Jung CY. Furosemide inhibits glucose transport in isolated rat adipocytes via direct inactivation of carrier proteins. Journal of Clinical Investigation 74: 1679–1685, 1984PubMedCrossRefGoogle Scholar
  21. Knochel JP. Diuretic induced hypokalemia. American Journal of Medicine 77: 18–27, 1984PubMedCrossRefGoogle Scholar
  22. Madias JE, Madias NE, Gavras HP. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension. Archives of Internal Medicine 144: 2171–2176, 1984PubMedCrossRefGoogle Scholar
  23. Majid PA, Meeran SB. Insulin and glucose in the treatment of heart failure. Lancet 2: 937–941, 1972PubMedCrossRefGoogle Scholar
  24. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. Journal of the American Medical Association 248: 1465–1477, 1982CrossRefGoogle Scholar
  25. Nachmansohn D, John HM. Studies on choline acetylase: I. Effects of amino acids on the dialyzed enzyme. Inhibition by α-keto acids. Journal of Biological Chemistry 158: 157–171, 1945Google Scholar
  26. Nardone DA, McDonald WJ, Girard DE. Mechanisms in hypokalemia: clinical correlation. Medicine 57: 435–446, 1978PubMedCrossRefGoogle Scholar
  27. Nordrehaug JE, Johannessen KA, Von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 71: 645–649, 1985PubMedCrossRefGoogle Scholar
  28. Paice B, Paterson KR, Onyanga-Omara F. Record linkage study of hypokalemia in hospitalized patients. Postgraduate Medicine 62: 187–191, 1980Google Scholar
  29. Papademetriou V, Burris JF, Notargiacoma A, Fletcher RD, Freis ED. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Archives of Internal Medicine 148: 1272–1276, 1988PubMedCrossRefGoogle Scholar
  30. Reid WD, Laragh JH. Sodium and potassium intake, blood pressure, and pressor response to angiotensin. Proceedings of the Society for Experimental Biology and Medicine 120: 26–29, 1965PubMedGoogle Scholar
  31. Singh BN, Collet JT, Chew CYC. New perspectives in the pharmacological therapy of cardiac arrhythmia. Progress in Cardiovascular Diseases 22: 243–301, 1980PubMedCrossRefGoogle Scholar
  32. Welt LG, Hollander Jr W, Blythe WB. The consequences of potassium depletion. Journal of Chronic Diseases 11: 213–254, 1960PubMedCrossRefGoogle Scholar
  33. Wilkinson PR, Hesp R, Issler H, Raftery EB. Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet 1: 759–762, 1975PubMedCrossRefGoogle Scholar
  34. Woods JW, Welt LG, Hollander W. Susceptibility of rats to experimental pyelonephritis following recovery from potassium depletion. Journal of Clinical Investigation 39: 28–33, 1959CrossRefGoogle Scholar

Copyright information

© Adis International Limited 1992

Authors and Affiliations

  • Gerald Isaac
    • 1
  • O. Bryan Holland
    • 1
  1. 1.Department of Internal MedicineUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations